The first results from Prepare - COVID symptoms, testing, shielding impact on patient reported outcomes and early vaccine responses in individuals with multiple myeloma https://t.co/z6cfqGIIcs
#CovidVaccine#research#myeloma#BloodCancer
π Great to see the issue of #vaccine effectiveness for people with #BloodCancer being discussed this morning on @GMB.
As @susannareid100 says, it's vital that we carry out more research. Help us fund this research by donating today: https://t.co/NZ5i5GEFeb #GiveShieldersAnswers
A huge thankyou to the over 200 participants who have so far signed up to our study looking at the efficacy of #COVID19Vaccine in Myeloma patients. We still need more participants and would particularly like to hear from particpants who have had #COVID19 1/2
@graham74GC Hi Graham, we are a new Covid-19 study sponsored by Oxford University and looking to recruit Myeloma participants. Would you mind giving us a follow and retweeting our latest tweet? Thanks!
@CR_UK Hi there, we are a new Covid-19 study sponsored by Oxford University and looking to recruit Myeloma participants. Would you mind giving us a follow and retweeting our latest tweet? Thanks!
@CR_UK Hi there, we are a new Covid-19 study sponsored by Oxford University and looking to recruit Myeloma participants. Would you mind giving us a follow and retweeting our latest tweet? Thanks!
@graham74GC Hi Graham, we are a new Covid-19 study sponsored by Oxford University and looking to recruit Myeloma participants. Would you mind giving us a follow and retweeting our latest tweet? Thanks!
We are looking for members of the #Myeloma community to get involved in our rapidly expanding Covid-19 study. For more information please visit https://t.co/IqPUScKUmP
January Newsletter
One month in and PREPARE has recruited over 100 participants.
We would like to say a massive thank you to all our participants and our team for helping PREPARE reach this milestone! @RudyStudy@MyelomaUK
RUDY is working with The PREPARE project which aims to understand the risk COVID-19 poses for patients with blood cancers @MyelomaUK@RDMOxford@PrepareStudy
https://t.co/ryCoEouAn9